- Report
- December 2024
- 150 Pages
Global
From €5472EUR$5,950USD£4,629GBP
- Report
- July 2024
- 202 Pages
Global
From €5472EUR$5,950USD£4,629GBP
- Report
- February 2025
- 200 Pages
Global
From €4129EUR$4,490USD£3,493GBP
- Report
- July 2023
- 135 Pages
Global
From €6898EUR$7,500USD£5,835GBP
- Report
- December 2023
- 168 Pages
Global
From €4552EUR$4,949USD£3,850GBP
- Report
- June 2023
- 204 Pages
Global
From €3311EUR$3,600USD£2,801GBP
- Report
- August 2022
- 324 Pages
Global
From €2472EUR$2,688USD£2,091GBP
€3532EUR$3,840USD£2,987GBP
Suboxone is a brand name for a combination of buprenorphine and naloxone, two medications used to treat opioid addiction. It is a partial opioid agonist, meaning it binds to opioid receptors in the brain, but does not produce the same level of euphoria as full opioid agonists. Suboxone is used to reduce cravings and withdrawal symptoms associated with opioid addiction, and to help people maintain abstinence from opioids. It is available in both tablet and film form, and is typically taken once or twice daily.
Suboxone is a popular treatment option for opioid addiction, as it is effective and has fewer side effects than other medications. It is also relatively easy to access, as it is available through both prescription and over-the-counter channels.
Companies in the Suboxone market include Reckitt Benckiser, which manufactures the brand name Suboxone, as well as generic versions of the drug. Other companies include Mylan, Teva Pharmaceuticals, and Sandoz. Show Less Read more